Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Assessment of Coronary Flow Reserve After Loading Dose of Ticagrelor vs Prasugrel in ACS Patients Undergoing PCI
2014-000197-19Phase 4Active
- Sponsor
- Azienda Ospedaliero-Universitaria Policlinico Umberto I
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in acute coronary syndrome (ACS) and myocardial infarction (MI) comparing Ticagrelor loading dose with Prasugrel loading dose (2 arms). Primary endpoint: Maximum coronary flow reserve after loading dose at increasing adenosine doses. Started Oct 2021; status: active.
02
Drugs
ticagrelorprasugrel
03
Conditions
acute coronary syndrome (ACS)myocardial infarction (MI)
Beyond the preview
Go deeper on 2014-000197-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000197-19.